Alignment Healthcare LLC
$ 20.63
-0.63%
10 Feb - close price
- Market Cap 4,127,892,000 USD
- Current Price $ 20.63
- High / Low $ 20.80 / 20.23
- Stock P/E N/A
- Book Value 0.81
- EPS -0.11
- Next Earning Report 2026-02-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE -0.15 %
- 52 Week High 23.87
- 52 Week Low 11.62
About
Alignment Healthcare, Inc. is an innovative healthcare provider dedicated to transforming care delivery for seniors in the United States through cutting-edge, consumer-centric technology. Headquartered in Orange, California, the company employs advanced data analytics and integrated care management to deliver personalized healthcare solutions aimed at improving patient outcomes while reducing costs. With the aging population on the rise and a significant shift towards value-based care in the healthcare industry, Alignment Healthcare is well-positioned to capitalize on these trends, making it an attractive investment opportunity for institutional investors looking to engage with the changing healthcare sector.
Analyst Target Price
$25.17
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-30 | 2025-07-30 | 2025-04-30 | 2025-02-25 | 2024-10-29 | 2024-08-01 | 2024-05-02 | 2024-02-27 | 2023-11-02 | 2023-08-03 | 2023-05-04 | 2023-02-28 |
| Reported EPS | 0.02 | 0.1382 | 0.0443 | -0.057 | -0.14 | -0.13 | -0.25 | -0.25 | -0.18 | -0.15 | -0.2 | -0.31 |
| Estimated EPS | -0.08 | -0.0616 | -0.072 | -0.084 | -0.14 | -0.14 | -0.22 | -0.22 | -0.18 | -0.22 | -0.25 | -0.3 |
| Surprise | 0.1 | 0.1998 | 0.1163 | 0.027 | 0 | 0.01 | -0.03 | -0.03 | 0 | 0.07 | 0.05 | -0.01 |
| Surprise Percentage | 125% | 324.3506% | 161.5278% | 32.1429% | 0% | 7.1429% | -13.6364% | -13.6364% | 0% | 31.8182% | 20% | -3.3333% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.15 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ALHC
2026-02-11 11:27:24
Andreas Wagner, an insider at Alignment Healthcare (NASDAQ:ALHC), sold 22,238 shares of the company's stock on February 10th for approximately $455,212. This transaction reduced his stake by 11.58% to 169,805 shares. The company has a market capitalization of $4.13 billion and analyst sentiment is "Moderate Buy" with an average target price of $23.32, while institutional ownership stands at about 86%.
2026-02-11 03:27:24
Alignment Healthcare's CHRO, Andreas P. Wagner, sold 22,238 shares for $455,211 to cover tax obligations, not as a discretionary trade. The company is experiencing significant growth, with projected health plan membership increases and raised price targets from KeyBanc, Piper Sandler, and JPMorgan, indicating strong performance in the Medicare Advantage sector.
2026-02-11 03:27:24
Alignment Healthcare (NASDAQ:ALHC) CEO John Kao sold 180,000 shares of the company's stock for a total of $3,688,200.00 on February 10th. This transaction reduced his stake by 6.35% to 2,652,641 shares. Despite the insider sale, analysts maintain a "Moderate Buy" consensus rating for ALHC with an average target price of $23.32.
2026-02-07 09:59:25
Wall Street Zen has upgraded Alignment Healthcare (NASDAQ:ALHC) from a "hold" to a "buy" rating, contributing to an average "Moderate Buy" rating among analysts with a $23.32 target price. Despite recent insider selling totaling $40.53 million, institutional investors hold a significant majority of the stock. Shares are currently trading around $21.75, showing a positive movement of approximately 2.8%.
2026-02-07 09:30:48
Alignment Healthcare (ALHC) shares recently closed at US$21.75, showing a 1-year return of 47.6%. A Discounted Cash Flow analysis suggests the stock is currently 16.9% overvalued, with an estimated intrinsic value of US$18.60 per share, while a Price-to-Sales ratio analysis indicates it is priced broadly in line with its fair value. Investors are encouraged to use "Narratives" on Simply Wall St to align their personal valuation assumptions with the company's financial forecasts.
2026-02-06 22:29:14
J.P. Morgan analyst John Stansel maintained a Buy rating on Alignment Healthcare (ALHC) with a price target of $26.00. This comes as the company reported a significant increase in quarterly revenue to $993.7 million, though corporate insider sentiment appears negative due to recent share sales. Other analysts also weighed in on ALHC, with Robert W. Baird issuing a Buy, while TipRanks – xAI reiterated a Hold rating.
